MHH investigates prevention of cervical cancer with HPV self-testing

- EN - DE
Dr Peter Hillemanns (left) and PD Dr Matthias Jentschke with the HPV self-tests
Dr Peter Hillemanns (left) and PD Dr Matthias Jentschke with the HPV self-tests
Dr Peter Hillemanns ( left ) and PD Dr Matthias Jentschke with the HPV self-tests - 20,000 women from the Hanover region to take part in study to improve prevention Cervical cancer is one of the most common diseases of the female reproductive organs. Human papilloma viruses, HPV for short, are almost always responsible for cervical cancer and the corresponding precancerous lesions. As part of the statutory preventive medical check-up, women from the age of 20 can have a cell smear taken from the cervix once a year, the so-called Pap test, to detect cell changes. From the age of 35, they are tested for human papilloma viruses every three years in combination with the Pap smear. The problem: 30 per cent of all women in Germany do not regularly take up the offer of statutory early detection. For women from socially disadvantaged backgrounds or with a migration background, this rate is even higher. A remedy could be an HPV self-testing procedure for which women would no longer have to go to the doctor's office.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.



Your Benefits

  • Access to all content
  • Receive newsmails for news and jobs
  • Post ads

myScience